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solidifying the available information to establish a knowl-
edge base, and how early trials of thrombolytic therapy
and observations during operative revascularization for
acute myocardial infarction supported the concept of
acute coronary thrombosis provide the important founda-
tion for this monograph.
What follows is a logical and stepwise progression of
the conceptual evolution of early myocardial reperfusion
as a result of scientifically rigorous clinical trials. The sem-
inal work performed in Europe and North America is
objectively documented.
The non-cardiologist may be unaware that the large
ISIS-2 trial showed the significant advantage of acute and
sustained administration of oral aspirin therapy in the early
hours of myocardial infarction. Aspirin was as good as
streptokinase alone, and the combination of streptokinase
and aspirin was significantly better than either alone or
placebo. Subsequently, there was the observation that the
earlier the thrombolysis, the better the survival advantage
and that survival was directly correlated to restoring
patency to the infarct related artery. Likewise, improved
myocardial function was also correlated with restoration of
patency to the infarct-related artery.
The larger GUSTO trials showed that patency rates
were measurably greater in patients undergoing heparin
therapy than in those undergoing aspirin therapy alone.
The interesting concept of pre-hospital thrombolysis
receives adequate attention, although in the mind of this
reviewer, I do not understand why it has not been more
widely adopted because its benefits were well described.
In the final chapters of this text, primary coronary
angioplasty for acute myocardial infarction is appropriate-
ly addressed. The preliminary results indicate that early
coronary reperfusion rates were similar with angioplasty as
compared with streptokinase. However, angioplasty was
better at preserving ventricular function at 1 week. Larger
trials are underway.
The text is written as a story and is enjoyable to read.
The imprimatur of Gerald Timmis, MD, is evident
throughout the book to the definite benefit of the reader.
The outline style is refreshing, with detailed headings eas-
ily directing the reader to areas of particular interest.
My major criticism of Thrombolytic therapy is that the
title of the text does not reflect its contents. This text only
covers thrombolytic therapy of acute myocardial infarc-
tion. Therefore, this should be the appropriate title of the
book. There is no background information on throm-
bolytic agents, their mechanism of action, or suggestions
as to why a particular lytic agent (or particular protocol)
may result in a more favorable outcome.
This text is particularly important reading to all who
are involved in the care of patients with acute myocardial
infarction and to those involved in the design of trials of
thrombolytic therapy. Although there are not many paral-
lels in lytic therapy for myocardial infarction and catheter-
directed thrombolysis for peripheral arterial disease, vascu-
lar surgeons will benefit by understanding the logical
sequential design of the clinical trials and appreciating
their major findings.
Anthony Comerota, MD
Temple University Hospital
Philadelphia, Pa
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The two editors are congratulated on their energy and
initiative in developing a regular meeting that acts as an
important update for European vascular surgeons.
Opinions from most European countries are represented
in the authorship, and there are also contributions from
the United States. This allows the display of a spectrum of
approaches to the critically ischemic leg.
Textbooks of this nature are considerable assets
because they provide focused attention on a defined area
within the full panoply of vascular disease. Major text-
books are unable to have the luxury of such diversity or to
provide more than 250 pages on one subject.
The editors have managed to coerce the authors to
submit their chapters in time for last year’s meeting so that
the views and referencing are current. All too frequently
textbooks are slightly out of date before they arrive on the
bookshelf. The assessment of critical ischemia covers not
only comparisons between duplex scanning and arteriog-
raphy but also assessment of the microcirculation. In other
words, the authors have not been confined to a narrow
surgical viewpoint but have looked at the problem in a
wider sense (another chapter covers “the importance of
the medical condition of the patient with critical
ischaemia”). The diversity of authors and the speed of
publication are also the source of some of the unevenness
amongst the chapters. For example, an excellent chapter
on the apparently straightforward topic of femoropopliteal
reconstruction has firm data on the epidemiology from
Scandinavian registries and also has a section on funda-
mental reporting problems. This chapter has 141 refer-
ences, whereas the chapter on in situ venous grafts keeps
the references down to 13. Many authors have clearly
given a considerable amount of thought and time to the
preparation of their chapter, but the high standard is
stained by a few who have been forced to hurry and cut
corners because of the impending deadline. This must be
a continuing frustration for editors of books related to
major postgraduate meetings because the provision of a
full chapter is a prerequisite of accepting the invitation.
With criticism of the few, the majority of the chapters
are well thought out and provide a rich resource of well-
illustrated and referenced information. Futura Books has
provided an attractive volume, with useful chapter and
page pagination on the outer margin of the page. I ques-
tion whether double columns in a book of this size might
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have been easier for reading. Reading horizontally seems
to be more difficult than reading vertically.
The many facets of critical ischemia are covered in this
textbook. The expected chapters on femoropopliteal and
femorocrural bypass grafting are here, and two full chap-
ters on the medical management of critical ischemia, a
chapter on spinal cord stimulation, and a chapter on “is
there a place for primary amputation?” provide a refresh-
ing balance. In conclusion, this is a useful reference on
critical ischemia that provides a European wide perspective
of the problem.
J.H.N Wolfe, MS, FRCS
St Mary’s Hospital
London, United Kingdom
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